Compare AWI & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AWI | KYMR |
|---|---|---|
| Founded | 1860 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.4B |
| IPO Year | 2006 | 2020 |
| Metric | AWI | KYMR |
|---|---|---|
| Price | $193.34 | $75.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 24 |
| Target Price | ★ $203.14 | $105.35 |
| AVG Volume (30 Days) | 381.9K | ★ 1.2M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | ★ 23.00 | N/A |
| EPS | ★ 6.97 | N/A |
| Revenue | ★ $1,600,200,000.00 | $43,735,000.00 |
| Revenue This Year | $14.13 | $18.71 |
| Revenue Next Year | $6.91 | N/A |
| P/E Ratio | $27.18 | ★ N/A |
| Revenue Growth | ★ 15.10 | N/A |
| 52 Week Low | $122.37 | $19.45 |
| 52 Week High | $206.08 | $103.00 |
| Indicator | AWI | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 55.59 | 47.34 |
| Support Level | $189.08 | $69.08 |
| Resistance Level | $203.30 | $77.75 |
| Average True Range (ATR) | 4.63 | 3.25 |
| MACD | 0.47 | -1.59 |
| Stochastic Oscillator | 50.75 | 36.28 |
Armstrong World Industries Inc. designs, innovates, and manufactures ceiling and wall solutions in the Americas. The company manufactures and sources products made of numerous materials, including mineral fiber, fiberglass, metal, felt, wood, resin, wood fiber, and glass-reinforced-gypsum. It also manufactures ceiling suspension system (grid) products through a joint venture with Worthington Industries, Inc., called Worthington Armstrong Venture (WAVE). The company's reportable operating segments include Mineral Fiber, Architectural Specialties, and Unallocated Corporate. A majority of its revenue is generated from the Mineral Fiber segment, which produces suspended mineral fiber and fiberglass ceiling systems. Geographically, it derives maximum revenue from the United States.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.